Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hammond

Showing results (481-490 of 555) with videos related to

Pageof 56
Sort By:
American Journal of Clinical Pathology|October 1, 1979
Childhood leukemia-lymphoma. Heterogeneity of phenotypes and prognosesJ H Kersey, T W LeBien, R Hurwitz, et al.
Medical and Pediatric Oncology|January 1, 1991
Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group studyW R Balsom, W A Bleyer, L L Robison, et al.
Medical and Pediatric Oncology|January 1, 1980
A new therapy schedule for pediatric non-Hodgkin lymphoma toxicity with preliminary resultsA T Meadows, R D Jenkin, J Anderson, et al.
Cancer|March 1, 1993
The Intergroup Rhabdomyosarcoma Study-IIH M Maurer, E A Gehan, M Beltangady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer GroupJ M Van Tornout, J D Buckley, J J Quinn, et al.
Cancer Research|November 15, 1990
Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patientsV I Avramis, J Champagne, J Sato, et al.
Medical and Pediatric Oncology|January 1, 1989
Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: a report from the Childrens Cancer Study GroupJ D Buckley, B C Lampkin, M E Nesbit, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 14, 2014
CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhageMatthew D Hammond, Roslyn A Taylor, Michael T Mullen, et al.
Blood|April 15, 1994
Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer GroupN A Heerema, D C Arthur, H Sather, et al.
Cancer|January 1, 1994
Treatment of overt isolated testicular relapse in children on therapy for acute lymphoblastic leukemia. A report from the Childrens Cancer GroupJ Z Finklestein, D R Miller, J Feusner, et al.
Pageof 56

Showing results (481-490 of 555) with videos related to

Sort By:
Pageof 56
American Journal of Clinical Pathology|October 1, 1979
Childhood leukemia-lymphoma. Heterogeneity of phenotypes and prognosesJ H Kersey, T W LeBien, R Hurwitz, et al.
Medical and Pediatric Oncology|January 1, 1991
Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group studyW R Balsom, W A Bleyer, L L Robison, et al.
Medical and Pediatric Oncology|January 1, 1980
A new therapy schedule for pediatric non-Hodgkin lymphoma toxicity with preliminary resultsA T Meadows, R D Jenkin, J Anderson, et al.
Cancer|March 1, 1993
The Intergroup Rhabdomyosarcoma Study-IIH M Maurer, E A Gehan, M Beltangady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer GroupJ M Van Tornout, J D Buckley, J J Quinn, et al.
Cancer Research|November 15, 1990
Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patientsV I Avramis, J Champagne, J Sato, et al.
Medical and Pediatric Oncology|January 1, 1989
Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: a report from the Childrens Cancer Study GroupJ D Buckley, B C Lampkin, M E Nesbit, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 14, 2014
CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhageMatthew D Hammond, Roslyn A Taylor, Michael T Mullen, et al.
Blood|April 15, 1994
Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer GroupN A Heerema, D C Arthur, H Sather, et al.
Cancer|January 1, 1994
Treatment of overt isolated testicular relapse in children on therapy for acute lymphoblastic leukemia. A report from the Childrens Cancer GroupJ Z Finklestein, D R Miller, J Feusner, et al.
Pageof 56